Protocol Ledger

NCT06841003 · Phase III · RECRUITING

Laparoscopic Antibiotic Lavage to Prevent Intra-abdominal Abscess Formation in Complicated Appendicitis

Interventional Phase III clinical trial protocol NCT06841003 sponsored by Spaarne Gasthuis in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-02-24 Enrollment: 752 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06841003
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)752 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06841003
Protocol FieldVerified Registry Value
NCT IdentifierNCT06841003
Consolidated Lead SponsorSpaarne Gasthuis
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment752 participants (ESTIMATED)
Registered Start Date2025-02-24
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI